Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX: PBT) covers the month of July 2008, specifically dated July 23, 2008. The registrant is a foreign private issuer based in South Melbourne, Australia. The filing serves as a notice under Section 708A(5) of the Corporations Act regarding the issuance of securities.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is a regulatory notice concerning a specific capital event rather than a financial performance report.
- Securities Issued: 80,000 Ordinary Fully Paid Shares
- Issue Date: July 23, 2008
- Issue Price: $Nil
Material Changes
The material change reported is the issuance of 80,000 ordinary shares without prior disclosure to investors under Part 6D.2 of the Corporations Act. The company intends to apply to the Australian Stock Exchange Limited for quotation of these shares. The filing confirms compliance with Chapter 2M and Section 674 of the Corporations Act as of the notice date.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. No unusual items or excluded information were reported.
Investor Verification Checklist
- Verify the successful quotation of the 80,000 newly issued shares on the ASX.
- Confirm the specific purpose of the $Nil share issuance (e.g., employee incentive, conversion, or other corporate action) as it is not detailed in this notice.
- Review subsequent filings for any dilution impact on existing shareholders.